Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118727434 | 11872743 | 4 | F | 201512 | 20160829 | 20151228 | 20160912 | EXP | FR-BIOGEN-2015BI00165266 | BIOGEN | 65.02 | YR | F | Y | 0.00000 | 20160912 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118727434 | 11872743 | 1 | PS | TYSABRI | NATALIZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125104 | 300 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | |||||||
| 118727434 | 11872743 | 2 | SS | FAMPYRA | DALFAMPRIDINE | 1 | Unknown | 22250 | UNKNOWN | ||||||||||
| 118727434 | 11872743 | 3 | C | TEGRETOL | CARBAMAZEPINE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 118727434 | 11872743 | 4 | C | PAROXETINE. | PAROXETINE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 118727434 | 11872743 | 5 | C | Vexicare | 2 | Unknown | 0 | UNKNOWN | |||||||||||
| 118727434 | 11872743 | 6 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 118727434 | 11872743 | 7 | C | paracetamol | ACETAMINOPHEN | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118727434 | 11872743 | 1 | Multiple sclerosis |
| 118727434 | 11872743 | 2 | Product used for unknown indication |
| 118727434 | 11872743 | 3 | Product used for unknown indication |
| 118727434 | 11872743 | 4 | Product used for unknown indication |
| 118727434 | 11872743 | 5 | Product used for unknown indication |
| 118727434 | 11872743 | 6 | Product used for unknown indication |
| 118727434 | 11872743 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118727434 | 11872743 | HO |
| 118727434 | 11872743 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118727434 | 11872743 | Asthenia | |
| 118727434 | 11872743 | Cognitive disorder | |
| 118727434 | 11872743 | Headache | |
| 118727434 | 11872743 | Lung adenocarcinoma metastatic |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118727434 | 11872743 | 1 | 201206 | 20151118 | 0 |